SAN FRANCISCO, July 23, 2018 /PRNewswire-PRWeb/ -- DoseSmart Inc. announced today that their proprietary medication adherence
"DoseSmart developed a custom version of their software that adapted to our study needs and provides us with real time adherence data on each study medication dose. In addition, the SmartBottle fits on the industry standard One-Click bottle created by Centor, seamlessly integrating the technologies with our patients' regimens." said Dr. Cramer. "We believe that DoseSmart will not only yield more accurate data for the purposes of our study, but potentially represent a tremendously useful tool for a broad scope of patient medication adherence."
"We are proud to be included in such an important and prestigious study such as Dr. Cramer's," stated DoseSmart spokesman David MacVittie. "We are confident that the study will bring to light the importance of regimented medication adherence as well as provide patients with an effective and easy-to-use system that yields optimal results from medications."
The trial commenced on July 1, 2018 with an estimated study completion date of December 31, 2018.
DoseSmart is the revolutionary way to ensure patients remember to take their pills on time, every time. DoseSmart Inc.'s patented technology provides a simple three-part solution to a complex problem of medication non-adherence. The first part is an easy-to-use Smartphone application where patients create custom schedules and set reminders for time, day and dosage of medications. The second part is the SmartBottle which stores, dispenses and tracks prescription medication and sends adherence data to the backend. The third part is a web-server driven data storage, presentation and analytics solution for use by care team support and/or clinical trials and research organizations. http://www.mydosesmart.com/
About Dr. Steven C. Cramer:
Dr. Steven C. Cramer is a Professor of Neurology, Anatomy & Neurobiology, and Physical Medicine & Rehabilitation at the University of California, Irvine. He is also the Associate Director of the Institute for Clinical & Translational Science at UC Irvine, and co-PI of the NIH StrokeNet clinical trials network. Dr. Cramer's research and clinical trials focus on neural repair after central nervous system injury in humans, with an emphasis on stroke and recovery of movement.
Study info: http://www.clinicaltrials.gov/ct2/show/NCT03460587 http://www.mydosesmart.com
Subscribe to our Free Newsletters!
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...
Drug interactions checker can be used to check over the counter ( OTC) and regular prescription ...
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...View All